Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.

about

TRIM28 is overexpressed in glioma and associated with tumor progression

P2860

Q57816336-644AAAEB-596A-4375-96D7-C72B23C7E481

P2860

Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q46469386

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Survival outcomes in pediatric ...... atic review and meta-analysis.

@en

Survival outcomes in pediatric ...... atic review and meta-analysis.

@nl

type

Item

label

Survival outcomes in pediatric ...... atic review and meta-analysis.

@en

Survival outcomes in pediatric ...... atic review and meta-analysis.

@nl

prefLabel

Survival outcomes in pediatric ...... atic review and meta-analysis.

@en

Survival outcomes in pediatric ...... atic review and meta-analysis.

@nl

P1476

Survival outcomes in pediatric ...... atic review and meta-analysis.

@en

P2093

Erin Felton

http://www.w3.org/2001/XMLSchema#string

I Elaine Allen

http://www.w3.org/2001/XMLSchema#string

Peggy Tahir

http://www.w3.org/2001/XMLSchema#string

Sabine Mueller

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

Temozolomide in paediatric high-grade glioma: a key for combination therapy?

Temozolomide in resistant or relapsed pediatric solid tumors.

Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma.

Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen.

Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide.

Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.

Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.

P2888

s11060-017-2701-8

P304

103-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1007/S11060-017-2701-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

C Kline

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204840

http://www.w3.org/2001/XMLSchema#string

P932

5823744

http://www.w3.org/2001/XMLSchema#string

Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.

about

P2860

P2860

Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932